These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32046269)

  • 1. Ocular Formulation Based on Palmitoylethanolamide-Loaded Nanostructured Lipid Carriers: Technological and Pharmacological Profile.
    Puglia C; Santonocito D; Ostacolo C; Maria Sommella E; Campiglia P; Carbone C; Drago F; Pignatello R; Bucolo C
    Nanomaterials (Basel); 2020 Feb; 10(2):. PubMed ID: 32046269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innovative Nanoparticles Enhance
    Puglia C; Blasi P; Ostacolo C; Sommella E; Bucolo C; Platania CBM; Romano GL; Geraci F; Drago F; Santonocito D; Albertini B; Campiglia P; Puglisi G; Pignatello R
    Front Pharmacol; 2018; 9():285. PubMed ID: 29643808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of Nanotechnological Carriers for Ocular Delivery of Mangiferin: Preformulation Study.
    Santonocito D; Vivero-Lopez M; Lauro MR; Torrisi C; Castelli F; Sarpietro MG; Puglia C
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of Lipid Nanoparticles by Response Surface Methodology to Improve the Ocular Delivery of Diosmin: Characterization and In-Vitro Anti-Inflammatory Assessment.
    Zingale E; Rizzo S; Bonaccorso A; Consoli V; Vanella L; Musumeci T; Spadaro A; Pignatello R
    Pharmaceutics; 2022 Sep; 14(9):. PubMed ID: 36145708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical Nanostructured Lipid Carrier Based Hydrogel of Mometasone Furoate for the Treatment of Psoriasis.
    Kaur N; Sharma K; Bedi N
    Pharm Nanotechnol; 2018; 6(2):133-143. PubMed ID: 29788899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Thermoresponsive Eyedrop Formulation Containing Ibuprofen Loaded-Nanostructured Lipid Carriers (NLC): Development, Characterization and Biocompatibility Studies.
    Almeida H; Lobão P; Frigerio C; Fonseca J; Silva R; Palmeira-de-Oliveira A; Lobo JM; Amaral MH
    Curr Drug Deliv; 2016; 13(6):953-70. PubMed ID: 26502890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
    Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
    Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
    Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa.
    Platania CBM; Dei Cas M; Cianciolo S; Fidilio A; Lazzara F; Paroni R; Pignatello R; Strettoi E; Ghidoni R; Drago F; Bucolo C
    Drug Deliv; 2019 Dec; 26(1):237-243. PubMed ID: 30883241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Influence of Process Parameters on the Properties of Resveratrol-Loaded NLC Using 2
    Shimojo AAM; Fernandes ARV; Ferreira NRE; Sanchez-Lopez E; Santana MHA; Souto EB
    Antioxidants (Basel); 2019 Aug; 8(8):. PubMed ID: 31382599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic Retinopathy Analysis-Effects of Nanoparticle-Based Triamcinolone.
    Du S; Wang H; Jiang F; Wang Y
    J Nanosci Nanotechnol; 2020 Oct; 20(10):6111-6115. PubMed ID: 32384959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of curcumin loaded lipid nanoparticles formulated using high shear homogenization (HSH) and ultrasonication (US) methods.
    Puglia C; Offerta A; Rizza L; Zingale G; Bonina F; Ronsisvalle S
    J Nanosci Nanotechnol; 2013 Oct; 13(10):6888-93. PubMed ID: 24245159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing SLN and NLC by 2(2) full factorial design: effect of homogenization technique.
    Severino P; Santana MH; Souto EB
    Mater Sci Eng C Mater Biol Appl; 2012 Aug; 32(6):1375-9. PubMed ID: 24364934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration.
    Okonogi S; Riangjanapatee P
    Int J Pharm; 2015 Jan; 478(2):726-35. PubMed ID: 25479097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanostructured lipid carriers engineered for intranasal delivery of teriflunomide in multiple sclerosis: optimization and in vivo studies.
    Gadhave DG; Kokare CR
    Drug Dev Ind Pharm; 2019 May; 45(5):839-851. PubMed ID: 30702966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characterization, identification and improved photo-stability of α-lipoic acid-loaded nanostructured lipid carrier.
    Wang J; Tang J; Zhou X; Xia Q
    Drug Dev Ind Pharm; 2014 Feb; 40(2):201-10. PubMed ID: 23336811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye.
    Araújo J; Nikolic S; Egea MA; Souto EB; Garcia ML
    Colloids Surf B Biointerfaces; 2011 Nov; 88(1):150-7. PubMed ID: 21764568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen.
    Almeida H; Lobão P; Frigerio C; Fonseca J; Silva R; Sousa Lobo JM; Amaral MH
    Pharm Dev Technol; 2017 May; 22(3):336-349. PubMed ID: 28240141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.